Asio Capital, LLC Novo Nordisk A S Transaction History

Asio Capital, LLC

$504 Million
Q4 2024

A detailed history of Asio Capital, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Asio Capital, LLC holds 5,301 shares of NVO stock, worth $445,443. This represents 0.09% of its overall portfolio holdings.

Number of Shares

5,301

Previous 5,035 5.28%

Holding current value

$445,443

Previous $599,000 24.04%

% of portfolio

0.09%

Previous 0.12%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 21, 2025	BUY	$85.0 - $120.04 $22,610 - $31,930	266 Added 5.28%	5,301 $455,000
Q1 2024 Apr 16, 2024	SELL	$102.11 - $135.92 $15,827 - $21,067	-155 Reduced 2.99%	5,035 $646,000
Q4 2023 Jan 11, 2024	BUY	$87.78 - $105.45 $41,256 - $49,561	470 Added 9.96%	5,190 $536,000
Q3 2023 Oct 31, 2023	BUY	$90.94 - $199.54 $214,618 - $470,914	2,360 Added 100.0%	4,720 $429,000
Q2 2023 Aug 03, 2023	SELL	$155.98 - $172.65 $31,195 - $34,530	-200 Reduced 7.81%	2,360 $381,000
Q1 2023 Apr 24, 2023	BUY	$132.34 - $159.14 $66,170 - $79,570	500 Added 24.27%	2,560 $407,000
Q3 2022 Oct 27, 2022	SELL	$95.28 - $116.93 $22,867 - $28,063	-240 Reduced 10.43%	2,060 $205,000
Q1 2022 Apr 28, 2022	SELL	$93.1 - $112.54 $9,310 - $11,254	-100 Reduced 4.17%	2,300 $255,000
Q4 2021 Feb 14, 2022	BUY	$95.88 - $117.08 $9,588 - $11,708	100 Added 4.35%	2,400 $269,000
Q3 2021 Nov 01, 2021	BUY	$84.42 - $106.62 $194,166 - $245,226	2,300 New	2,300 $221,000
Q3 2020 Oct 15, 2020	SELL	$63.69 - $70.22 $146,487 - $161,506	-2,300 Closed	0 $0
Q2 2020 Jul 31, 2020	SELL	$58.54 - $67.94 $1,463 - $1,698	-25 Reduced 1.08%	2,300 $151,000
Q1 2020 Apr 28, 2020	SELL	$49.46 - $64.78 $7,419 - $9,717	-150 Reduced 6.06%	2,325 $140,000
Q4 2019 Feb 14, 2020	BUY	$49.86 - $58.26 $123,403 - $144,193	2,475 New	2,475 $143,000

Others Institutions Holding NVO

# of Institutions

1,879

Shares Held

317M

Call Options Held

5.49M

Put Options Held

7.77M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $190B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Asio Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Asio Capital, LLC with notifications on news.

Account